Cerebral ischemia: New risk factors

被引:21
作者
Diaz, J
Sempere, AP [1 ]
机构
[1] Hosp Vega Baja, S Neurol, ES-03314 Orihuela, Spain
[2] Hosp 12 Octubre, S Neurol, E-28041 Madrid, Spain
关键词
cerebral infarction; risk factors; infection; homocysteine; sleep apnea syndromes;
D O I
10.1159/000074794
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stroke is a disease with well-defined modifiable risk factors such as arterial hypertension, smoking, diabetes, hyperlipidemia and atrial fibrillation. The need of new risk factors is based on the fact that only half the cardiovascular disease risk is explained by conventional risk factors. Inflammatory markers, infection, homocysteine and sleep-disordered breathing rank as the four most important new risk factors in cerebral atherosclerosis. C-reactive protein is the inflammatory marker that has been most thoroughly studied. Elevated concentrations of C-reactive protein increase the risk of heart disease and thromboembolic stroke in men and women. The role of Chlamydia pneumoniae is still controversial. Influenza vaccination is a simple and effective preventive measure against stroke. Despite the potential relationship between homocysteine and stroke, we should wait to the results of the ongoing trials to know if the reduction of homocysteine levels with vitamin therapy is of clinical benefit. Sleep-disordered breathing is a potential new risk factor with an effective therapy. Neurologists should not forget to look for sleep disorders in their stroke patients and probably manage them with breathing therapy from the acute phase. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 80 条
  • [1] PLASMA-LIPOPROTEINS IN CORTICAL VERSUS LACUNAR INFARCTION
    ADAMS, RJ
    CARROLL, RM
    NICHOLS, FT
    MCNAIR, N
    FELDMAN, DS
    FELDMAN, EB
    THOMPSON, WO
    [J]. STROKE, 1989, 20 (04) : 448 - 452
  • [2] AMARENCO P, 1998, CEREBROVASC DIS, V8, P2
  • [3] Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study
    Anderson, JL
    Muhlestein, JB
    Carlquist, J
    Allen, A
    Trehan, S
    Nielson, C
    Hall, S
    Brady, J
    Egger, M
    Horne, B
    Lim, T
    [J]. CIRCULATION, 1999, 99 (12) : 1540 - 1547
  • [4] Sleep apnea in acute cerebrovascular diseases: Final report on 128 patients
    Bassetti, C
    Aldrich, MS
    [J]. SLEEP, 1999, 22 (02) : 217 - 223
  • [5] Sleep apnea in pat ischemic attack and stroke: A prospective study of 59 patients
    Bassetti, C
    Aldrich, MS
    Chervin, RD
    Quint, D
    [J]. NEUROLOGY, 1996, 47 (05) : 1167 - 1173
  • [6] Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
    Blauw, GJ
    Lagaay, AM
    Smelt, AHM
    Westendorp, RGJ
    [J]. STROKE, 1997, 28 (05) : 946 - 950
  • [7] SPONTANEOUS PLATELET ACTIVATION AND AGGREGATION DURING OBSTRUCTIVE SLEEP-APNEA AND ITS RESPONSE TO THERAPY WITH NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE
    BOKINSKY, G
    MILLER, M
    AULT, K
    HUSBAND, P
    MITCHELL, J
    [J]. CHEST, 1995, 108 (03) : 625 - 630
  • [8] Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia - The West Birmingham Stroke Project
    Cook, PJ
    Honeybourne, D
    Lip, GYH
    Beevers, DG
    Wise, R
    Davies, P
    [J]. STROKE, 1998, 29 (02) : 404 - 410
  • [9] Reductase inhibitor monotherapy and stroke prevention
    Crouse, JR
    Byington, RP
    Hoen, HM
    Furberg, CD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (12) : 1305 - 1310
  • [10] Risk factors for stroke and type of stroke in persons with isolated systolic hypertension
    Davis, BR
    Vogt, T
    Frost, PH
    Burlando, A
    Cohen, J
    Wilson, A
    Brass, LM
    Frishman, W
    Price, T
    Stamler, J
    [J]. STROKE, 1998, 29 (07) : 1333 - 1340